Analysis of suggested that patients with more advanced ovarian cancer (those with an advanced FIGO stage) have increased tumoral linc-ROR expression; furthermore, linc-ROR expression was higher in ovarian cancer tissues from patients with than without lymph node metastases. Here, LINC-ROR is linked to metastatic malignant neoplasm in the lymph nodes.